Orexo Ab Stock Number Of Employees
| ORX Stock | SEK 9.55 0.15 1.60% |
Orexo AB fundamentals help investors to digest information that contributes to Orexo AB's financial success or failures. It also enables traders to predict the movement of Orexo Stock. The fundamental analysis module provides a way to measure Orexo AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orexo AB stock.
Orexo |
Orexo AB Company Number Of Employees Analysis
Orexo AB's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Orexo AB Number Of Employees | 126 |
Most of Orexo AB's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orexo AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Orexo AB is currently employing 126 people. This is 98.85% lower than that of the Pharmaceuticals sector and 97.23% lower than that of the Health Care industry. The number of employees for all Sweden stocks is 99.33% higher than that of the company.
Orexo AB is regarded third in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 312. Orexo AB totals roughly 126 in number of employees claiming about 40% of equities under Health Care industry.Orexo Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0965 | |||
| Profit Margin | (0.28) % | |||
| Operating Margin | (0.29) % | |||
| Current Valuation | 795.36 M | |||
| Shares Outstanding | 34.35 M | |||
| Shares Owned By Insiders | 17.29 % | |||
| Shares Owned By Institutions | 42.78 % | |||
| Price To Earning | 14.08 X | |||
| Price To Book | 2.34 X | |||
| Price To Sales | 1.14 X | |||
| Revenue | 624.3 M | |||
| Gross Profit | 521.7 M | |||
| EBITDA | (116.3 M) | |||
| Net Income | (183.9 M) | |||
| Cash And Equivalents | 697 M | |||
| Cash Per Share | 19.64 X | |||
| Total Debt | 519 M | |||
| Debt To Equity | 69.40 % | |||
| Current Ratio | 2.21 X | |||
| Book Value Per Share | 5.64 X | |||
| Cash Flow From Operations | (156.6 M) | |||
| Earnings Per Share | (6.28) X | |||
| Target Price | 38.0 | |||
| Number Of Employees | 126 | |||
| Beta | 0.72 | |||
| Market Capitalization | 612.75 M | |||
| Total Asset | 1.11 B | |||
| Working Capital | 553 M | |||
| Current Asset | 845 M | |||
| Current Liabilities | 292 M | |||
| Z Score | 0.6 | |||
| Net Asset | 1.11 B |
About Orexo AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orexo AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orexo AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orexo AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.